50 studies found for:    "Localized scleroderma"
Show Display Options
Rank Status Study
1 Recruiting Fractional Carbon Dioxide Laser Versus UVA 1 in Treatment of Localized Scleroderma
Condition: Localized Scleroderma
Interventions: Device: Fractional carbon dioxide laser;   Device: Ultraviolet A1 phototherapy (UVA1)
2 Recruiting Morphea in Adults and Children (MAC) Cohort Study: A Morphea Registry and DNA Repository
Conditions: Scleroderma, Localized;   Morphea;   Frontal Linear Scleroderma en Coup de Sabre;   Scleroderma, Circumscribed;   Scleroderma, Linear
Intervention: Other: Morphea
3 Recruiting Treatment Study Comparing UVA-1 Phototherapy Versus Placebo Treatment for Morphea
Conditions: Scleroderma, Localized;   Morphea;   Scleroderma, Circumscribed
Interventions: Procedure: UVA-1 Phototherapy;   Procedure: Placebo
4 Completed Imiquimod in Children With Plaque Morphea
Condition: Scleroderma, Localized
Intervention: Drug: Imiquimod 5% cream
5 Withdrawn Imiquimod 5% Cream in Plaque-Type Morphea: A Pilot, Prospective Open-Label Study
Condition: Morphea
Intervention: Drug: imiquimod 5% cream (Aldara)
6 Unknown  Treatment Study Comparing Medium or High Dose Uva-1 Treatment 3x/Week Versus Fluocinonide 0.05% Cream in the Treatment of Morphea.
Condition: Symmetric Limited Morphea.
Interventions: Other: Medium Dose UVA-1;   Other: High Dose UVA-1
7 Recruiting Genetic Variants in Linear Localized Scleroderma
Condition: Morphea
Intervention: Other: skin biopsy
8 Recruiting The CARRA Registry
Conditions: Juvenile Idiopathic Arthritis;   Systemic Lupus Erythematosus;   Mixed Connective Tissue Disease;   Juvenile Ankylosing Spondylitis;   Juvenile Dermatomyositis;   Localized Scleroderma;   Systemic Sclerosis;   Vasculitis;   Sarcoid;   Fibromyalgia, Primary;   Auto-inflammatory Disease;   Idiopathic Uveitis Idiopathic
Intervention:
9 Completed Efficacy and Safety of Imatinib in Scleroderma
Conditions: Scleroderma, Localized;   Scleroderma, Systemic
Intervention: Drug: imatinib mesylate
10 Completed Ultraviolet B (UVB) Light Therapy in the Treatment of Skin Conditions With Altered Dermal Matrix
Conditions: Keloid;   Scleroderma, Localized;   Acne Keloidalis;   Scars;   Granuloma Annulare
Intervention: Procedure: UVB Irradiation
11 Active, not recruiting A Protocol Based Treatment for Debilitating Fibrosing Skin Disorders With (Anti-CD 20), Rituximab, Evaluating Safety and Efficacy
Condition: Debilitating Fibrosing Skin Disorders (Localised Scleroderma, Eosinophilic Fasciitis)
Intervention: Drug: Rituximab
12 Recruiting Scleroderma Lung: Role of Gastroesophageal Reflux, Microaspiration and Cough
Condition: Scleroderma Lung
Intervention:
13 Recruiting Scleroderma Registry & Repository at the Hospital for Special Surgery
Condition: Scleroderma
Intervention:
14 Completed
Has Results
Safety Evaluation of Dasatinib in Subjects With Scleroderma Pulmonary Fibrosis
Condition: Scleroderma
Intervention: Drug: dasatinib
15 Completed
Has Results
High Dose Cyclophosphamide for Treatment of Scleroderma
Condition: Scleroderma
Intervention: Drug: IV Cyclophosphamide
16 Terminated Proof of Concept Trial of Gleevec (Imatinib) in Active Diffuse Scleroderma
Condition: Scleroderma
Interventions: Drug: Imatinib mesylate;   Other: Placebo
17 Completed A Study to Evaluate Safety and Tolerability of Multiple Doses of MEDI-546 in Adult Subjects With Scleroderma
Condition: Scleroderma
Intervention: Drug: MEDI-546
18 Recruiting Effect of Bosentan in Scleroderma Renal Crisis
Condition: Scleroderma Renal Crisis
Intervention: Drug: Bosentan
19 Completed
Has Results
Cyclophosphamide and rATG With Hematopoietic Stem Cell Support in Systemic Scleroderma
Condition: SYSTEMIC SCLERODERMA
Interventions: Drug: standard of care;   Procedure: stem cell transplantation
20 Recruiting Calcinosis in a Single-Center Scleroderma Population
Conditions: Scleroderma;   Calcinosis
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years